Research projects

Johns Hopkins researchers receive millions for new cancer research projects

Enter Wall Street with StreetInsider Premium. Claim your one week free trial here.

The Departments of Pathology, Neurosurgery, and Gynecology/Obstetrics and the Johns Hopkins Kimmel Cancer Center have received nearly $8 million for new research projects aimed at discovering cures for a number of deadly cancers, including ovarian cancer, pancreatic cancer and glioblastoma. The projects are funded by Break Through Cancer, a cancer research foundation, as part of an effort for researchers at a quintet of cancer research centers.

Other cancer research centers include the University of Texas MD Anderson Cancer Center in…

Learn more>>

NOTICE TO INVESTORS: The latest news and updates regarding CNS Pharmaceuticals Inc. (NASDAQ: CNSP) can be found in the company’s newsroom at

About BioMedWire

BioMedWire (BMW) is a biomedical news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries, and demographics in the most effective manner possible, (2) syndication of stories and articles to over 5,000 news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution through the Investor Brand Network (IBN) to nearly 2 million subscribers, (5) a full suite of business communications solutions, and (6) a complete of news coverage with BMW Premier. As a multi-faceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to better serve private and public companies seeking to reach a wide audience of investors, consumers, journalists and the general public. By reducing the information overload in today’s market, BMW provides customers with unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS alerts from BioMedWire, text “Biotech” to 844-397-5787 (US cell phones only)

For more information, please visit

Please review the full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever posted or republished:

BioMedWire (BMW)
San Francisco, California
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.